Ticker Scorecard - ATRA Basics Company: Atara Biotherapeutics, Inc. IPO Date: October 16, 2014 Sector: Healthcare Industry: Biotech Market Cap: $40.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.64 | 3.91% Avg Daily Range (30 D): $0.69 | 7.05% Avg Daily Range (90 D): $0.59 | 5.51% Institutional Daily Volume Avg Daily Volume: .04M Avg Daily Volume (30 D): .27M Avg Daily Volume (90 D): .16M Trade Size Avg Trade Size (Sh.): 7 Avg Trade Size (Sh.) (30 D): 106 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 2,724 Avg Inst. Trade: $2.22M Avg Inst. Trade (30 D): $.52M Avg Inst. Trade (90 D): $.52M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2M Avg Closing Trade (30 D): $4.55M Avg Closing Trade (90 D): $4.55M Avg Closing Volume: 6.14K     News Jan 30, 2025 @ 10:39 PM Wolf Haldenstein Adler Freeman & Herz LLP announce... Source: N/A Nov 20, 2024 @ 9:47 PM FUJIFILM Diosynth Biotechnologies Celebrates the E... Source: Fujifilm Diosynth Biotechnologies Jul 17, 2024 @ 11:03 AM Presenting on the Emerging Growth Conference 73 Da... Source: N/A May 23, 2024 @ 2:06 PM Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease... Source: Zacks Equity Research May 22, 2024 @ 3:12 PM GSK Studies on Depemokimab for Severe Asthma Meet ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $42.4 $-2.93 $-3.1 Diluted EPS $42.4 $-2.93 $-3.1 Revenue $ 100.44M $ 40.19M $ 28.64M Gross Profit $ $ $ Net Income / Loss $ -133.16M $ -21.91M $ -19.05M Operating Income / Loss $ -131.2M $ -21.76M $ -18.23M Cost of Revenue $ $ $ Net Cash Flow $ -18.34M $ 15.14M $ -3.77M PE Ratio 0.17     Splits Jun 20, 2024:   25:1